172 related articles for article (PubMed ID: 11371204)
1. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.
Ono M; Handa K; Sonnino S; Withers DA; Nagai H; Hakomori S
Biochemistry; 2001 May; 40(21):6414-21. PubMed ID: 11371204
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility.
Kawakami Y; Kawakami K; Steelant WF; Ono M; Baek RC; Handa K; Withers DA; Hakomori S
J Biol Chem; 2002 Sep; 277(37):34349-58. PubMed ID: 12068006
[TBL] [Abstract][Full Text] [Related]
3. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.
Ono M; Handa K; Withers DA; Hakomori S
Cancer Res; 1999 May; 59(10):2335-9. PubMed ID: 10344740
[TBL] [Abstract][Full Text] [Related]
4. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
Ono M; Handa K; Withers DA; Hakomori S
Biochem Biophys Res Commun; 2000 Dec; 279(3):744-50. PubMed ID: 11162423
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor through interaction of ganglioside GM3 with GlcNAc of N-linked glycan of the receptor: demonstration in ldlD cells.
Guan F; Handa K; Hakomori SI
Neurochem Res; 2011 Sep; 36(9):1645-53. PubMed ID: 21203834
[TBL] [Abstract][Full Text] [Related]
7. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
Satoh M; Ito A; Nojiri H; Handa K; Numahata K; Ohyama C; Saito S; Hoshi S; Hakomori SI
Int J Oncol; 2001 Oct; 19(4):723-31. PubMed ID: 11562747
[TBL] [Abstract][Full Text] [Related]
8. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
9. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.
Ikeyama S; Koyama M; Yamaoko M; Sasada R; Miyake M
J Exp Med; 1993 May; 177(5):1231-7. PubMed ID: 8478605
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM.
Kazui A; Ono M; Handa K; Hakomori S
Biochem Biophys Res Commun; 2000 Jun; 273(1):159-63. PubMed ID: 10873579
[TBL] [Abstract][Full Text] [Related]
12. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
Miura Y; Kainuma M; Jiang H; Velasco H; Vogt PK; Hakomori S
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16204-9. PubMed ID: 15534203
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
14. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
Ovalle S; Gutiérrez-López MD; Olmo N; Turnay J; Lizarbe MA; Majano P; Molina-Jiménez F; López-Cabrera M; Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
Int J Cancer; 2007 Nov; 121(10):2140-52. PubMed ID: 17582603
[TBL] [Abstract][Full Text] [Related]
15. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
[TBL] [Abstract][Full Text] [Related]
16. Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2004 Aug; 279(33):34655-64. PubMed ID: 15143068
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside.
Yim SH; Farrer RG; Hammer JA; Yavin E; Quarles RH
J Neurosci Res; 1994 Jun; 38(3):268-81. PubMed ID: 7523687
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
19. GT3 synthesis in the proximal Golgi occurs in a compartment different from those for GD3 and GM3 synthesis.
Rosales Fritz VM; Maxzúd MK; Maccioni HJ
J Neurochem; 1996 Oct; 67(4):1393-400. PubMed ID: 8858920
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster ovary cell motility to fibronectin is modulated by the second extracellular loop of CD9. Identification of a putative fibronectin binding site.
Longhurst CM; Jacobs JD; White MM; Crossno JT; Fitzgerald DA; Bao J; Fitzgerald TJ; Raghow R; Jennings LK
J Biol Chem; 2002 Sep; 277(36):32445-52. PubMed ID: 12068019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
